TY  - CHAP
M1  - Book, Section
TI  - Obesity
A1  - Saunders, Katherine H.
A1  - Igel, Leon I.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Key  Clinical  Updates  in  ObesitySemaglutide,  a  GLP-1  receptor  agonist,  is  FDA-approved  for  the  treatment  of  obesity.Wilding  JPH  et  al.  N  Engl  J  Med.  [PMID:  33567185]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193133619
ER  -